These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 11007262)

  • 21. Interferon alpha-2b and ribavirin for patients with chronic hepatitis C and normal ALT.
    Mukherjee S
    Am J Gastroenterol; 2005 Mar; 100(3):727; author reply 727. PubMed ID: 15743377
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronic hepatitis C viral infection with persistent normal serum alanine aminotransferases].
    Huang CX; Bai XF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):70-1. PubMed ID: 15670508
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged therapy for hepatitis C with low-dose peginterferon.
    Poynard T; Ratziu V
    N Engl J Med; 2009 Mar; 360(11):1152; author reply 1152-3. PubMed ID: 19283890
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin.
    Sherker AH; Senosier M; Kermack D
    Hepatology; 2003 Jan; 37(1):223. PubMed ID: 12500209
    [No Abstract]   [Full Text] [Related]  

  • 25. Prolonged therapy for hepatitis C with low-dose peginterferon.
    Koretz RL; Gluud C
    N Engl J Med; 2009 Mar; 360(11):1151; author reply 1152-3. PubMed ID: 19279350
    [No Abstract]   [Full Text] [Related]  

  • 26. A short period of interferon therapy led to a sustained response in two cases of chronic hepatitis C.
    Tabaru A; Ono M; Narita R; Abe S; Nakamura H; Yoshikawa I; Otsuki M
    J Gastroenterol Hepatol; 2001 Aug; 16(8):947-8. PubMed ID: 11555117
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatitis C in Egypt, a iatrogenic epidemic].
    Vrolijk JM; Schalm SW
    Ned Tijdschr Geneeskd; 2000 Dec; 144(49):2378. PubMed ID: 11129975
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical utility of early viral load quantification.
    Colucci G
    Hepatology; 2000 Jul; 32(1):158. PubMed ID: 10905877
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic hepatitis C and normal ALT: considerations for treatment.
    Bacon BR
    Am J Gastroenterol; 2004 Sep; 99(9):1706-7. PubMed ID: 15330906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic hepatitis C in nonresponders to interferon monotherapy.
    Kwo PY
    Curr Gastroenterol Rep; 2000 Feb; 2(1):11-7. PubMed ID: 10980998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [When standard therapy fails. New therapy options in chronic hepatitis C].
    MMW Fortschr Med; 2001 Jan; 143(3):53-4. PubMed ID: 11215347
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
    Yoshikawa M; Mimura M; Shiroi A; Kojima H; Fukui H; Sugimoto Y; Mochi T
    Am J Gastroenterol; 2000 Sep; 95(9):2396-7. PubMed ID: 11007259
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter: sustained virological response and liver healing.
    Rossotti R; Garcia-Fraile Fraile LJ; Baiguera C; Puoti M
    Aliment Pharmacol Ther; 2017 Apr; 45(8):1171-1173. PubMed ID: 28326575
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels.
    Nutt AK; Hassan HA; Lindsey J; Lamps LW; Raufman JP
    Am J Med; 2000 Jul; 109(1):62-4. PubMed ID: 10936480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Successful treatment in a case of type-C fulminant hepatitis with interferon and steroid-pulse therapy, and review of its virological aspects].
    Marusawa H; Yamashita Y; Kajimura K; Kumegawa Y; Takaya H; Katsurada A
    Nihon Shokakibyo Gakkai Zasshi; 1996 Aug; 93(8):583-7. PubMed ID: 8810818
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term virological response and growth rate of children with chronic hepatitis C who received natural interferon-alpha.
    Shiraki K; Morishima T; Terasawa S; Koike M; Fujisawa T; Tajiri H;
    Eur J Pediatr; 2002 Nov; 161(11):629-30. PubMed ID: 12532945
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment with silymarin for hepatitis C virus.
    Ferenci P
    JAMA; 2012 Nov; 308(18):1856-7; author reply 1857. PubMed ID: 23149997
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and virological changes in serum of nonresponder or relapser chronic hepatitis C patients retreated with interferon and ribavirin followed by interferon alone.
    Cuccorese G; Tursi A; Spinazzola AM; Modeo ME; Miglietta A
    Am J Gastroenterol; 2000 Sep; 95(9):2399-400. PubMed ID: 11007262
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response.
    Petrenkiene V; Gudinaviciene I; Jonaitis L; Kupcinskas L
    Medicina (Kaunas); 2004; 40(6):538-46. PubMed ID: 15208476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.